Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 999 results for "first pharma"

Swedish pharma firm partners GVK Bio for drug research

ered into a partnership with GVK Biosciences for drug research. This is the first pact the city-based clinical research the company has inked after it got involved in regulatory issues with European Medicines Agency a few months ago. Medivir is a ... Business Standard, 2 weeks ago
GVK Bio extends partnership with Akaal Pharma Economic Times, 4 days ago

213 images for first pharma

MyNewsDesk, 8 hours ago
Business Standard, 5 days ago
Pharma Letter, 3 days ago
Business Standard, 4 hours ago
Business Standard, 7 hours ago
Business Standard, 11 hours ago
Business Standard, 9 hours ago
American Journal of Transportation On-Line, 5 days ago
Indian Country Today Media Network, 2 weeks ago
Business Standard, 3 days ago
Optometry Today

First Apple Watch app for visually impaired people July 3 2015 ViaOpta Nav is the first navigation app available for a wearable device which has been designed specifically for visually impaired people

Rated 0 Log In to Add to Favourites July 3 2015 Novartis Pharmaceuticals has launched the first app for visually impaired people which can be used on the Apple Watch, as well as other smart watches. Established as part of an update ...
 Optometry Today7 hours ago Novartis Pharmaceuticals launches the first app for visually impaired people for use with the Apple Watch and other smart watches  Fierce Biotech IT1 day ago Novartis introduces first app for visually impaired people for use with Apple Watch & other smart watches  PharmaBiz5 days ago Novartis Launches First App For Visually Impaired People To Use With Apple Watch, Other Smart Watches  Medical Design Online3 days ago

Equity & equity-linked issuances at 8-year high on Sun Pharma deal, CIL divestment

India's equity and equity-linked fund raising in the first six months of calendar 2015 surged to an eight-year high, with many large corporations tapping capital markets anticipating capital expenditure and debt reduction requirements. According ...
 Financial Express4 days ago Equity issuances jump 2.7 times in first half of 2015  Smart Investor5 days ago Earnings will improve from the second half of 2015-16: Swati Kulkarni, UTI AMC  Economic Times13 hours ago

Capital First, HDFC Bank, Glenmark Pharma and Bajaj Auto preferred picks: Hemang Jani, Sharekhan

We think that this is a good time to actually go in the market and start accumulating good stocks, says Hemang Jani.
 Economic Times3 days ago HSBC (00005) to distribute first interim dividend on 8 July days ago

French company signs first distribution agreement with Fujifilm Pharma

Advanced Accelerator Applications S.A. (AAA), France-based specialist in Molecular Nuclear Medicine (MNM), has entered into a distribution agreement for Lutathera in Japan with Fujifilm RI Pharma Co. LTD (FRI), a leading distributor of nuclear ...
 Bio Spectrum Asia5 days ago AAA Signs Distribution Agreement for Lutathera in Japan with FUJIFILM RI Pharma, Co., LTD  Citybizlist5 days ago
India Infoline

Intas to launch its first biosimilar in US in 9-12 mths

Intas Pharmaceuticals, a vertically integrated pharma company, today said it expects to launch its first biosimilar in the US within 9-12 months. Intas is the only domestic firm with two biosimilars filed for registration in the US and it looks to ...
 Business Standard2 weeks ago Biosimilars licensing agreements for...  GaBi Online3 days ago Intas Pharma plans to launch its first biosimilar in US: Reports  India Infoline2 weeks ago

Guwahati could emerge as pharma hub for South East Asia: Ananth Kumar

To be spread across 89 acres of land, the first phase of construction, amounting to Rs 160 cr, has started from today and that the total project cost would be to the tune of Rs 550 cr BS Reporter | Guwahati May 31, 2015 Last Updated at 20:18 IST Guwahati ...
 Business Standard1 month ago

Students take oath for code of ethics at first pharma convocation

Taking the "Oath for Code of Pharmaceutical Ethics", 62 students of the University Institute of Pharmaceutical Sciences (UIPS) pledged to maintain integrity, quality standards, sincerity and ethical approach in their professional lives at the first-ever ...
 Times of India2 months ago

Pharma Jan Samadhan, an on-line system launched to take action related to non-availability and overcharging of medicines

All essential medicines specified in the National List of Essential Medicines, 2011 (NLEM) are included in the First Schedule of DPCO, 2013 and are under price control. However, Life saving drugs are not defined in the Drugs (Price Control) Order, 2013.
 PIB2 months ago

Adapt Pharma Acquires Narcan NDA and Obtains License to the NarcanĀ® Trademark

DUBLIN--(EON: Enhanced Online News Narcan was the first naloxone product approved by the U.S. Food and Drug Administration (FDA) as a treatment for opioid overdose in 1971. Narcan has not been distributed under the brand name since 2009; however, ...
 EON: Enhanced Online News4 days ago Adapt Pharma acquires Narcan NDA, secures license to Narcan trademark  Pharmaceutical Business Review3 hours ago Adapt Pharma Acquires Narcan NDA  Citybizlist3 days ago 7/2/15 - Adapt Pharma Acquires Narcan NDA and Obtains License to the NarcanĀ® Trademark  Pharmacy Choice3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less